<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  <title>Why Moderna (MRNA) Shares Are Falling Today</title>
</head>
<body>
  <a href="../../index.html">← Back to home</a>
  <h1>Why Moderna (MRNA) Shares Are Falling Today</h1>
  <ul>
<li>Moderna is down 42.9% since the beginning of the year, and at $23.99 per share, it is trading 69.8% below its 52-week high of $79.51 from September 2024.</li>
<li>Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 4.8% in the afternoon session after competitors Pfizer and BioNTech announced positive topline results for their updated 2025-2026 COVID-19 vaccine formula.</li>
<li>What Is The Market Telling Us Moderna’s shares are extremely volatile and have had 50 moves greater than 5% over the last year.</li>
<li>The previous big move we wrote about was 12 days ago when the stock gained 3.6% on the news that the company announced it received U.S.</li>
<li>Food and Drug Administration (FDA) approval for its updated COVID-19 vaccines for the 2025-2026 season.</li>
<li>Investors who bought $1,000 worth of Moderna’s shares 5 years ago would now be looking at an investment worth $441.46.</li>
<li>At the conference, CEO Stéphane Bancel outlined strategic priorities but also noted the company faces market uncertainties and is targeting cash flow break-even by 2028.</li>
</ul>
<p><a href="https://finance.yahoo.com/news/why-moderna-mrna-shares-falling-182630851.html">Source</a> · 2025-09-08T18:26:30+00:00</p>
</body>
</html>